先天性甲状腺功能减退症新生儿筛查:双筛程序中使用差异化TSH切值获益
意大利伦巴第大区2007-2014年双筛程序回顾分析119例第二次筛查确诊的先天性甲状腺功能减退症(CH)患儿,比较第二次筛查干血斑促甲状腺激素(bTSH)5.0-9.9 mU/L与≥10 mU/L两组。两组甲状腺发育不良、永久性与暂时性CH频率相似;低bTSH组早产儿、NICU入住及母亲妊娠期糖皮质激素治疗、母亲甲状腺功能减退和/或甲状腺肿比例更高。结论:第二次筛查采用5.0 mU/L切值可识别早产儿及具相关风险因素的新生儿。
要点
- 第二次筛查bTSH 5.0-9.9 mU/L组早产儿和NICU入住比例显著高于≥10 mU/L组。
- 低bTSH组母亲妊娠期糖皮质激素治疗及母亲甲状腺功能减退和/或甲状腺肿更常见。
- 第二次筛查5.0 mU/L切值有助于发现早产儿及具相关风险因素的CH新生儿。
核心结论
- 第二次筛查采用较低TSH切值(5.0 mU/L)可检测出更多CH病例,适合识别早产儿及具相关风险因素的新生儿。
研究设计与样本
- 回顾性分析意大利伦巴第地区2007至2014年双筛程序第二次筛查确诊的119例CH婴儿。
- 第一次筛查(所有婴儿)bTSH切值10 mU/L,第二次筛查(选定婴儿)bTSH切值5 mU/L。
主要发现
- 两组甲状腺发育不良与在位腺体频率相似,永久性与暂时性CH频率也相似,且两组均发现高频率甲状腺外畸形。
- 低bTSH组较高bTSH组早产儿比例(57.7% vs 23.9%,P < .001)和NICU入住比例(50.0% vs 17.9%,P < .001)显著更高。
- 低bTSH组较高bTSH组母亲妊娠期糖皮质激素治疗(11.5% vs 1.5%,P = .042)及母亲甲状腺功能减退和/或甲状腺肿(26.9% vs 10.4%,P = .036)显著更常见。
关键数值与推荐
- 第一次筛查bTSH切值10 mU/L(所有婴儿),第二次筛查bTSH切值5 mU/L(选定婴儿)。
- 第二次筛查bTSH 5.0-9.9 mU/L与≥10.0 mU/L分组比较。
临床怎么用
- 双筛程序中第二次筛查采用5.0 mU/L切值可提高对早产儿及具相关风险因素CH新生儿的检出。
- 对早产儿、NICU入住儿及母亲有妊娠期糖皮质激素治疗或甲状腺疾病史的新生儿应关注第二次筛查bTSH结果。
局限性
- 回顾性分析,仅纳入意大利伦巴第地区2007至2014年第二次筛查确诊的119例CH婴儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Analysis of a 2-screen program for congenital hypothyroidism (CH) was performed using differential dried-blood spot thyrotropin (bTSH) cutoffs of 10 mU/L at first screening (all infants) and 5 mU/L at second screening (selected infants). OBJECTIVES: This work aimed to characterize CH infants identified by the second screening and compare infants with bTSH of 5.0 to 9.9 and 10 mU/L or greater on second screening. DESIGN AND PATIENTS: Maternal and neonatal clinical features were retrospectively analyzed for 119 CH babies detected on the second screen in the Lombardy region of Italy, 2007 to 2014. RESULTS: Fifty-two (43.7%) of the 119 CH neonates showed bTSH values ranging from 5.0 to 9.9 mU/L at the second screening (low bTSH group) and 67 (56.3%) bTSH of 10.0 mU/L or greater (high bTSH group). The frequency of thyroid dysgenesis and eutopic gland was similar in both groups, as was the frequency of permanent and transient CH. Moreover, a high frequency of extrathyroidal malformations was found in both groups. The percentage of preterm infants (57.7% vs 23.9%, P < .001) and infants admitted to the neonatal intensive care unit (50.0% vs 17.9%, P < .001) was significantly higher in the low vs the high bTSH group. In addition, maternal treatment with glucocorticoids in pregnancy was significantly more frequent in the low bTSH group than in the high bTSH group (11.5% vs 1.5%, P = .042), as well as maternal hypothyroidism and/or goiter (26.9% vs 10.4%, P = .036). CONCLUSIONS: This study has demonstrated that a lower TSH cutoff at the second screening can detect additional cases of CH and that a second bTSH cutoff of 5.0 mU/L is appropriate for identifying preterm newborns and babies with associated risk factors.
引用
- Caiulo S, Corbetta C, Di Frenna M, et al. Newborn Screening for Congenital Hypothyroidism: the Benefit of Using Differential TSH Cutoffs in a 2-Screen Program. J Clin Endocrinol Metab. 2021. PMID: 33124651. doi:10.1210/clinem/dgaa789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。